Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Seegene Ink MDx Development Agreement

NEW YORK (GenomeWeb) – Seegene will develop a menu of multiplex assay panels for Qiagen's QIAsymphony RGQ molecular diagnostics platform under a partnership announced by the companies today.

The first project under the partnership is to develop comprehensive panels to profile infectious diseases. Seegene's proprietary technologies for multiplexed real-time PCR analysis enable simultaneous amplification of up to 20 target genes per tube.

Qiagen will validate the tests to run on the QIAsymphony RGQ, its modular, automated, real-time PCR-based molecular MDx system, and will market the assays worldwide as Qiagen-branded products, beginning in Europe and Asia.

"Seegene's technologies can test for multiple targets with high sensitivity [and] reproducibility, and the panels offer significant medical value," Thierry Bernard, senior vice president and head of molecular diagnostics at Qiagen, said in a statement.

"Collaborating with Qiagen to commercialize comprehensive multiplexed panels based on our innovative PCR chemistry technologies will expand Seegene's global reach," Seegene Founder and CEO Jong-Yoon Chun noted in a statement. "Because our breakthrough MuDT technology enables detection and quantification of multiple target genes in a single channel without melt curve analysis, this is a true next-generation qPCR technology."

This is the second major global original design manufacturing deal that Seegene has entered into. In November, Seegene and Beckman Coulter inked a deal under which Seegene will manufacture reagents for Beckman Coulter's new Veris MDx sample-to-answer molecular diagnostics system.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.